Skip to main content
Top
Published in: Annals of Hematology 6/2011

01-06-2011 | Original Article

Expansion of CD4+CD25+ regulatory T cells from cord blood CD4+ cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin

Authors: Shinsuke Asanuma, Junji Tanaka, Junichi Sugita, Mizuha Kosugi, Souichi Shiratori, Kentarou Wakasa, Yusuke Shono, Akio Shigematsu, Takeshi Kondo, Takahiko Kobayashi, Masahiro Asaka, Masahiro Imamura

Published in: Annals of Hematology | Issue 6/2011

Login to get access

Abstract

Rapamycin has important roles in the modulation of regulatory T cells. We tried to expand CD4 + CD25 + regulatory T cells (Treg cells) from umbilical cord blood (CB) CD4-positive cells using interleukin (IL)-15 or IL-2 with transforming growth factor (TGF)-β and rapamycin. We were able to obtain more than 500-fold expansion of CD4+CD25+ cells from CB CD4+ cells using IL-15 and TGF-β with rapamycin. These expanded CD4+CD25+ cells expressed forkhead box P3 (FoxP3) mRNA at a level about 100-fold higher and could suppress allogeneic mixed lymphocyte culture (MLC) by more than 50%. Early after rapamycin stimulation, CB CD4+ cells showed increased expression of FoxP3 and a serine/threonine kinase Pim2 and sustained expression of negative phosphoinositide 3-kinase regulator phosphatase and tensin homolog deleted on chromosome 10 (PTEN). On the other hand, CD4+CD25+ cells expanded with rapamycin for 8 days showed much higher levels of FoxP3 mRNA expression and decreased expression of PTEN. A comparison of IL-15 stimulation and IL-2 stimulation showed slightly higher efficiency of IL-15 for expansion of CD4 + CD25 + cells, and for FoxP3 expression, IL-15 also showed significantly higher efficacy for inhibition of MLC. The combination of the common γ-chain cytokine IL-15, TGF-β, and rapamycin may be a useful means for expanding Treg cells. Pim2 expression early after stimulation with rapamycin may be important for conferring rapamycin resistance for growth of Treg cells. IL-15 is not less useful than IL-2 for expansion of Treg cells.
Literature
1.
go back to reference Nguyen VH, Zeiser R, Negrin RS (2006) Role of naturally arising regulatory T cells in hematopoietic cell transplantation. Biol Blood Marrow Transplant 12:995–1009PubMedCrossRef Nguyen VH, Zeiser R, Negrin RS (2006) Role of naturally arising regulatory T cells in hematopoietic cell transplantation. Biol Blood Marrow Transplant 12:995–1009PubMedCrossRef
2.
go back to reference Rezvani K, Mielke S, Ahmadzadeh M et al (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108:1291–1297PubMedCrossRef Rezvani K, Mielke S, Ahmadzadeh M et al (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108:1291–1297PubMedCrossRef
3.
go back to reference Xia G, He J, Zhang Z, Leventhal JR (2006) Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells. Transplantation 82:1749–1755PubMedCrossRef Xia G, He J, Zhang Z, Leventhal JR (2006) Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells. Transplantation 82:1749–1755PubMedCrossRef
4.
go back to reference Godfrey WR, Ge YG, Spoden DJ et al (2004) In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104:453–461PubMedCrossRef Godfrey WR, Ge YG, Spoden DJ et al (2004) In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104:453–461PubMedCrossRef
5.
go back to reference Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA (2004) Natural and induced CD4+CD25+ cells educate CD4+CD25− cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 172:5213–5221PubMed Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA (2004) Natural and induced CD4+CD25+ cells educate CD4+CD25− cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 172:5213–5221PubMed
6.
go back to reference Godfrey WR, Spoden DJ, Ge YG et al (2005) Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105:750–758PubMedCrossRef Godfrey WR, Spoden DJ, Ge YG et al (2005) Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105:750–758PubMedCrossRef
7.
go back to reference Li L, Godfrey WR, Porter SB et al (2005) CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106:3068–3073PubMedCrossRef Li L, Godfrey WR, Porter SB et al (2005) CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106:3068–3073PubMedCrossRef
8.
go back to reference Tanaka J, Sugita J, Kato N et al (2007) Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit. Exp Hematol 35:1562–1566PubMedCrossRef Tanaka J, Sugita J, Kato N et al (2007) Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit. Exp Hematol 35:1562–1566PubMedCrossRef
9.
go back to reference Thomson AW, Turnquist HR, Raimondi G (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9:324–337PubMedCrossRef Thomson AW, Turnquist HR, Raimondi G (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9:324–337PubMedCrossRef
10.
go back to reference Battaglia M, Stabilini A, Roncarolo MG (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105:4743–4748PubMedCrossRef Battaglia M, Stabilini A, Roncarolo MG (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105:4743–4748PubMedCrossRef
11.
go back to reference Valmori D, Tosello V, Souleimanian NE et al (2006) Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol 177:944–949PubMed Valmori D, Tosello V, Souleimanian NE et al (2006) Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol 177:944–949PubMed
12.
go back to reference Strauss L, Whiteside TL, Knights A, Bergmann C, Knuth A, Zippelius A (2007) Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J Immunol 178:320–329PubMed Strauss L, Whiteside TL, Knights A, Bergmann C, Knuth A, Zippelius A (2007) Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J Immunol 178:320–329PubMed
13.
go back to reference Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457–462PubMedCrossRef Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457–462PubMedCrossRef
14.
go back to reference Walsh PT, Buckler JL, Zhang J et al (2006) PTEN inhibits IL-2 receptor-mediated expansion of CD4+CD25+ Tregs. J Clin Investig 116:2521–2531PubMed Walsh PT, Buckler JL, Zhang J et al (2006) PTEN inhibits IL-2 receptor-mediated expansion of CD4+CD25+ Tregs. J Clin Investig 116:2521–2531PubMed
15.
go back to reference Zeiser R, Leveson-Gower DB, Zambricki EA et al (2008) Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 111:453–462PubMedCrossRef Zeiser R, Leveson-Gower DB, Zambricki EA et al (2008) Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 111:453–462PubMedCrossRef
16.
go back to reference Fox CJ, Hammerman PS, Thompson CB (2005) The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med 201:259–266PubMedCrossRef Fox CJ, Hammerman PS, Thompson CB (2005) The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med 201:259–266PubMedCrossRef
17.
go back to reference Basu S, Golovina T, Mikheeva T, June CH, Riley JL (2008) Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 180:5794–5798PubMed Basu S, Golovina T, Mikheeva T, June CH, Riley JL (2008) Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 180:5794–5798PubMed
18.
go back to reference Giri JG, Ahdieh M, Eisenman J et al (1994) Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822–2830PubMed Giri JG, Ahdieh M, Eisenman J et al (1994) Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822–2830PubMed
19.
go back to reference Demirci G, Li XC (2004) IL-2 and IL-15 exhibit opposing effects on Fas mediated apoptosis. Cell Mol Immunol 1:123–128PubMed Demirci G, Li XC (2004) IL-2 and IL-15 exhibit opposing effects on Fas mediated apoptosis. Cell Mol Immunol 1:123–128PubMed
20.
go back to reference Lin SJ, Cheng PJ, Hsiao SS, Lin HH, Hung PF, Kuo ML (2005) Differential effect of IL-15 and IL-2 on survival of phytohemagglutinin-activated umbilical cord blood T cells. Am J Hematol 80:106–112PubMedCrossRef Lin SJ, Cheng PJ, Hsiao SS, Lin HH, Hung PF, Kuo ML (2005) Differential effect of IL-15 and IL-2 on survival of phytohemagglutinin-activated umbilical cord blood T cells. Am J Hematol 80:106–112PubMedCrossRef
21.
go back to reference Carson WE, Giri JG, Lindemann MJ et al (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395–1403PubMedCrossRef Carson WE, Giri JG, Lindemann MJ et al (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395–1403PubMedCrossRef
22.
go back to reference Rutella S, Pierelli L, Bonanno G et al (2001) Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions. Exp Hematol 29:1503–1516PubMedCrossRef Rutella S, Pierelli L, Bonanno G et al (2001) Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions. Exp Hematol 29:1503–1516PubMedCrossRef
23.
go back to reference Lin SJ, Cheng PJ, Yan DC, Lee PT, Hsaio HS (2006) Effect of interleukin-15 on alloreactivity in umbilical cord blood. Transpl Immunol 16:112–116PubMedCrossRef Lin SJ, Cheng PJ, Yan DC, Lee PT, Hsaio HS (2006) Effect of interleukin-15 on alloreactivity in umbilical cord blood. Transpl Immunol 16:112–116PubMedCrossRef
24.
go back to reference Chen W, Jin W, Hardegen N et al (2003) Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875–1886PubMedCrossRef Chen W, Jin W, Hardegen N et al (2003) Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875–1886PubMedCrossRef
25.
go back to reference Hippen KL, Harker-Murray P, Porter SB et al (2008) Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood 112:2847–2857PubMedCrossRef Hippen KL, Harker-Murray P, Porter SB et al (2008) Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood 112:2847–2857PubMedCrossRef
26.
go back to reference Burchill MA, Yang J, Vang KB, Farrar MA (2007) Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett 114:1–8PubMed Burchill MA, Yang J, Vang KB, Farrar MA (2007) Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett 114:1–8PubMed
27.
go back to reference Zeiser R, Negrin RS (2008) Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy. Cell Cycle 15:458–462CrossRef Zeiser R, Negrin RS (2008) Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy. Cell Cycle 15:458–462CrossRef
28.
go back to reference Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA (2007) IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 178:280–290PubMed Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA (2007) IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 178:280–290PubMed
29.
go back to reference Johnston JA, Bacon CM, Finbloom DS et al (1995) Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 92:8705–8709PubMedCrossRef Johnston JA, Bacon CM, Finbloom DS et al (1995) Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 92:8705–8709PubMedCrossRef
30.
go back to reference Hess AD (2006) Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Biol Blood Marrow Transplant 12:13–21PubMedCrossRef Hess AD (2006) Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Biol Blood Marrow Transplant 12:13–21PubMedCrossRef
31.
32.
go back to reference Hoffmann P, Boeld TJ, Eder R, Albrecht J, Doser K, Piseshka B, Dada A, Niemand C, Assenmacher M, Orsó E, Andreesen R, Holler E, Edinger M (2006) Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant 12:267–274PubMedCrossRef Hoffmann P, Boeld TJ, Eder R, Albrecht J, Doser K, Piseshka B, Dada A, Niemand C, Assenmacher M, Orsó E, Andreesen R, Holler E, Edinger M (2006) Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant 12:267–274PubMedCrossRef
33.
go back to reference Trzonkowski P, Bieniaszewska M, Juścińska J, Dobyszuk A, Krzystyniak A, Marek N, Myśliwska J, Hellmann A (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells. Clin Immunol 133:22–26PubMedCrossRef Trzonkowski P, Bieniaszewska M, Juścińska J, Dobyszuk A, Krzystyniak A, Marek N, Myśliwska J, Hellmann A (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells. Clin Immunol 133:22–26PubMedCrossRef
34.
go back to reference Battaglia M (2010) Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go? Transpl Int 23:761–770PubMedCrossRef Battaglia M (2010) Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go? Transpl Int 23:761–770PubMedCrossRef
35.
go back to reference Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, McGlave PB, Blazar BR, Wagner JE (2010) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood (in press). doi:10.1182/blood-2010-07-293795 Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, McGlave PB, Blazar BR, Wagner JE (2010) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood (in press). doi:10.​1182/​blood-2010-07-293795
Metadata
Title
Expansion of CD4+CD25+ regulatory T cells from cord blood CD4+ cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin
Authors
Shinsuke Asanuma
Junji Tanaka
Junichi Sugita
Mizuha Kosugi
Souichi Shiratori
Kentarou Wakasa
Yusuke Shono
Akio Shigematsu
Takeshi Kondo
Takahiko Kobayashi
Masahiro Asaka
Masahiro Imamura
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 6/2011
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-010-1121-z

Other articles of this Issue 6/2011

Annals of Hematology 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.